OPTIEUM BIOTECHNOLOGIES

Optieum Biotechnologies Inc. is a pre-clinical stage biotechnology company committed to developing innovative scFv antibody-based therapies for the treatment of patients with cancers. Their proprietary platform technology, Eumbody System™, enables to develop and detect a scFv-based product candidates that specifically bind to, and modulate to optimize the immune-cell function for oncology targets. We are committed to helping patients with severe diseases by bringing life-changing therapies to the patients in need.